Table 2.

Recommendations for lipoprotein (a) risk thresholds from different societies

Societal position	Lipoprotein (a) risk threshold
2018 American Heart Association/ American College of Cardiology Multisociety Guidelines [47••]	>50 mg/dL (>125 nmol/L)
2019 National Lipid Association Scientific Statement [48]	>50 mg/dL or >100 nmol/L (based on >80th populations percentile in Caucasians)
2019 European Society of Cardiology and European Atherosclerosis Society [49••]	Lp(a) > 180 mg/dL (>430 nmol/L) is defined as risk threshold equivalent to that for heterozygous FH
2019 HEART UK Consensus Statement [43]	Risk thresholds: 32–90 nmol/L minor; 90–200 nmol/L moderate; 200–400 nmol/L high; >400 nmol/L very high
2016 Canadian Cardiovascular Society Guidelines [50]	>30 mg/dL

Abbreviations: ESC; European Society of Cardiology EAS; European Atherosclerosis Society, FH; Familial Hypercholesterolemia